For: | Zhang CJ, Zhang JY, Li LJ, Xu NW. Refractory lymphoma treated with chimeric antigen receptor T cells combined with programmed cell death-1 inhibitor: A case report. World J Clin Cases 2022; 10(21): 7502-7508 [PMID: 36157987 DOI: 10.12998/wjcc.v10.i21.7502] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i21/7502.htm |
Number | Citing Articles |
1 |
|